SETD2-KIF9 Fusion FISH Probe
The SETD2-KIF9 Fusion FISH Probe is used to confirm a fusion of the SETD2 and KIF9 genes. The fusion of the SETD2 and KIF9 genes has been associated with Lung Adenocarcinoma, and Uterine Carcinosarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SETD2-KIF9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SETD2-KIF9-20-AQAQ | 20 (40 μL) | 200 μL |
|
SETD2 Gene Summary
Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008]
Gene Name: SET Domain Containing 2
Chromosome: CHR3: 47057897 -47205467
Locus: 3p21.31
KIF9 Gene Summary
The Kinesin Family Member 9 (KIF9) gene is located on chr3 :47269515-47324337 at 3p21.31.
Gene Name: Kinesin Family Member 9
Chromosome: CHR3: 47269515 -47324337
Locus: 3p21.31
Gene Diseases
The SETD2 KIF9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
| Uterine Carcinosarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|